American pharma giant Pfizer ($PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded ...

Pfizer Inc. (NYSE:PFE) ranks among the best stocks under $25 to buy now. Citing the company’s cautious 2026 outlook, BMO ...

GSK (GSK) and other leading drugmakers plans to raise prices of as many as 350 medicines next year, with a median hike of ...

Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...

TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer today and set a price target of $30.00. According to TipRanks, Scala is a 4-star analyst with an average return of 11.3% and a 64.82% ...

While Pfizer Inc's (NYSE:PFE) revenue trends remained uneven in the third quarter, the company exhibited "continued cost discipline," according to Goldman Sachs. The Pfizer Analyst: Analyst Asad ...

Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the December 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...

Pfizer stock (NYSE: PFE) is currently in a significant slump, marking its ninth consecutive day of decline and losing a total of −11% of its value over that period. This sustained sell-off has wiped ...

Pfizer disclosed a patient death in a marstacimab hemophilia study, triggering a safety review and reassessment of surgical ...